PharmaBoardroom

The managing director of MSD in Mexico explains why the Mexican pharmaceutical market is an attractive market in which to compete, but not one that…

The country manager of one of the foremost providers of sustainable and integrated healthcare solutions describes the sorts of local adaptations…

A recent arrival from China, Lilly's Turkey MD Daniel Lucas assesses the country’s healthcare system and raises key questions about the…

MSD Turkey has benefited in recent years from the ability to engage in local business development initiatives, and managing director Hatice Demiray…

GSK’s VP and Area GM Pharmaceuticals, Turkey and Caucasus, and chairman of Turkey’s innovative pharmaceutical association, discusses the…

Biocodex’s new general manager gives an overview of the affiliates ‘new deal’ program, and how the company has adjusted its approach to better…

The general manager of Daiichi Sankyo Turkey discusses his affiliate's expansion into a regional hub, current strategies for growth in the Turkish…

The general manager of a speciality biopharma business challenges lawmakers to regard health spending not as a cost but as an investment and reveals…

One of the new cohort of country managers speaks out about Romania's blossoming potential as a manufacturing hub and explains in detail how his firm…

The country manager and Global Established Products Business Lead at Pfizer South Africa reveals how the private sector is committed to expanding…

In public health everything is a priority. The Undersecretary of Prevention and Health Promotion explains how Mexico’s Ministry of Health is…

Many of the multinational companies with a long-standing presence in Latin America used to have factories in Peru – since the 1990s all of these…